Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Frontiers in Immunology|March 27, 2020
Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and TherapeuticsVinayaka Kotraiah, Timothy W Phares, Cecille D Browne, et al.
Frontiers in Immunology|April 23, 2020
Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics ToolsAnne S De Groot, Leonard Moise, Frances Terry, et al.
Plos One|September 24, 2014
A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidateAmy R Noe, Diego Espinosa, Xiangming Li, et al.
Infection and Immunity|November 30, 2016
The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking VaccinesDiego A Espinosa, Joel Vega-Rodriguez, Yevel Flores-Garcia, et al.
American Journal of Lifestyle Medicine|June 23, 2025
Lifestyle Interventions for Treatment and Remission of Type 2 Diabetes and Prediabetes in Adults: A Clinical Practice Guideline From the American College of Lifestyle MedicineRichard M Rosenfeld, Meagan L Grega, Micaela C Karlsen, et al.
American Journal of Lifestyle Medicine|June 23, 2025
Executive Summary of Lifestyle Interventions for Treatment and Remission of Type 2 Diabetes and Prediabetes in Adults: A Clinical Practice Guideline From the American College of Lifestyle MedicineRichard M Rosenfeld, Meagan L Grega, Micaela C Karlsen, et al.
Frontiers in Cellular and Infection Microbiology|January 6, 2023
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical settingJulie Healer, Jennifer K Thompson, Karen L Mackwell, et al.
Nature Communications|June 7, 2024
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complexBarnabas G Williams, Lloyd D W King, David Pulido, et al.
Cell Reports. Medicine|July 17, 2024
Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodiesLloyd D W King, David Pulido, Jordan R Barrett, et al.
Cell|July 26, 2024
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotypeJordan R Barrett, Dimitra Pipini, Nathan D Wright, et al.
Pageof 12